New tool helps nasal cancer patients voice their satisfaction
NCT ID NCT07257094
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times
Summary
This study aims to validate a French version of the Nasal Reconstruction FACE-Q questionnaire, which measures how patients feel about their appearance, quality of life, and side effects after nasal reconstruction or prosthetic rehabilitation following nasal skin cancer surgery. About 346 adults who had surgery 4 months to 3 years ago will participate. The goal is to provide a reliable tool for doctors to better understand patient satisfaction and improve care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Caen
NOT_YET_RECRUITINGCaen, 14000, France
-
CHU Toulouse
NOT_YET_RECRUITINGToulouse, 31400, France
-
Centre Antoine Lacassagne
RECRUITINGNice, 06000, France
-
HNIA Toulon
RECRUITINGToulon, 83000, France
-
Hopital Novo
RECRUITINGPontoise, 95300, France
-
Hôpital Bichat (APHP)
NOT_YET_RECRUITINGParis, 75018, France
-
Hôpital Lariboisière (AP-HP)
NOT_YET_RECRUITINGParis, 75010, France
-
Institut Curie
NOT_YET_RECRUITINGParis, 75005, France
-
Institut Gustave Roussy
RECRUITINGVillejuif, 94800, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Pre-Surgery immunotherapy prime the immune system to fight head and neck cancer?
- Can a new immune drug outsmart Hard-to-Treat tumors?
- Can a Two-Pronged attack shrink Hard-to-Treat cancers?
- Could your workout history affect your Cancer's genes?
- New combo therapy aims to stop liver cancer from coming back
- New drug combo takes on advanced cancers in early trial